BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 5477935)

  • 1. Cytotoxicity in vitro of preleukaemic lymphoid cells on syngeneic monolayers of embryo or thymus cells.
    Wahren B; Metcalf D
    Clin Exp Immunol; 1970 Sep; 7(3):373-86. PubMed ID: 5477935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 5. [The reactivity of human embryo lymphoid cells in an in vitro culture].
    Govallo VI; Grigor'eva MP; Kopelian II
    Biull Eksp Biol Med; 1970 Jan; 69(1):80-3. PubMed ID: 5430719
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 7. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus function in spontaneous lymphoid leukemia. II. In vitro response of "preleukemic" and leukemic thymus cells to mitogens.
    Nagaya H
    J Immunol; 1973 Oct; 111(4):1052-60. PubMed ID: 4728674
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative and qualitative study of myeloid chloroleukemia virus based on the resistance phenomenon.
    Prigozhina EL; Stavrovskaya AA
    Fed Proc Transl Suppl; 1965; 24(5):929-32. PubMed ID: 4284566
    [No Abstract]   [Full Text] [Related]  

  • 11. B-lymphocyte colony forming cells in the thymus of AKR mice.
    Gjedde SB
    Exp Hematol; 1980 Apr; 8(4):375-83. PubMed ID: 6970136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogenesis of the in vitro response of murine lymphoid cells to cellular antigens and phytomitogens.
    Howe ML; Manziello B
    J Immunol; 1972 Sep; 109(3):534-9. PubMed ID: 5055182
    [No Abstract]   [Full Text] [Related]  

  • 13. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antilymphocytic and antithymocytic sera on the development of mouse lymphoma.
    Vredevoe DL; Hays EF
    Cancer Res; 1969 Sep; 29(9):1685-90. PubMed ID: 5822478
    [No Abstract]   [Full Text] [Related]  

  • 15. The specificity of antilymphocyte sera to thymic, splenic, and leukemic lymphocytes.
    Asakuma R; Reif AE
    Cancer Res; 1968 Apr; 28(4):707-15. PubMed ID: 5649060
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of C58 mice by normal murine tissues against transplantable leukemia, line Ib.
    Han IH; Johnson AG; Murphy WH
    J Natl Cancer Inst; 1969 May; 42(5):815-24. PubMed ID: 5785010
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E; Otiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between presence of leukemia virus in cultured cells and their immunogenicity in a leukemia isotransplant system.
    Tennant JR; Lambertenghi G; Kingsley S; de Harven E
    J Natl Cancer Inst; 1971 Oct; 47(4):781-8. PubMed ID: 4328948
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of antigen-binding cells for five diverse antigens at the onset of lymphoid development: lack of evidence for somatic diversification during ontogeny.
    Decker JM; Clarke J; Bradley LM; Miller A; Sercarz EE
    J Immunol; 1974 Dec; 113(6):1823-33. PubMed ID: 4610048
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.